Robert F.  McCadden net worth and biography

Robert McCadden Biography and Net Worth

Lead Independent Trustee of the Trust. Former Executive Vice President and Chief Financial Officer of Pennsylvania Real Estate Investment Trust; formerly a Partner of KPMG LLP and Arthur Andersen LLP; Lead Independent Trustee of the Trust

What is Robert F. McCadden's net worth?

The estimated net worth of Robert F. McCadden is at least $466.92 thousand as of May 9th, 2024. Mr. McCadden owns 11,644 shares of Universal Health Realty Income Trust stock worth more than $466,924 as of December 5th. This net worth approximation does not reflect any other investments that Mr. McCadden may own. Learn More about Robert F. McCadden's net worth.

How do I contact Robert F. McCadden?

The corporate mailing address for Mr. McCadden and other Universal Health Realty Income Trust executives is UNIVERSAL CORPORATE CENTER 367 SOUTH GULPH ROAD, KING OF PRUSSIA PA, 19406. Universal Health Realty Income Trust can also be reached via phone at (610) 265-0688. Learn More on Robert F. McCadden's contact information.

Has Robert F. McCadden been buying or selling shares of Universal Health Realty Income Trust?

Robert F. McCadden has not been actively trading shares of Universal Health Realty Income Trust during the past quarter. Most recently, on Thursday, May 9th, Robert F. Mccadden bought 2,000 shares of Universal Health Realty Income Trust stock. The stock was acquired at an average cost of $37.38 per share, with a total value of $74,760.00. Following the completion of the transaction, the director now directly owns 11,644 shares of the company's stock, valued at $435,252.72. Learn More on Robert F. McCadden's trading history.

Who are Universal Health Realty Income Trust's active insiders?

Universal Health Realty Income Trust's insider roster includes Michael Domb (Director), Robert McCadden (Director), and Alan Miller (CEO). Learn More on Universal Health Realty Income Trust's active insiders.

Are insiders buying or selling shares of Universal Health Realty Income Trust?

In the last year, Universal Health Realty Income Trust insiders bought shares 1 times. They purchased a total of 12,247 shares worth more than $453,383.94. The most recent insider tranaction occured on October, 29th when CEO Alan B Miller bought 12,247 shares worth more than $453,383.94. Insiders at Universal Health Realty Income Trust own 2.4% of the company. Learn More about insider trades at Universal Health Realty Income Trust.

Information on this page was last updated on 10/29/2025.

Robert F. McCadden Insider Trading History at Universal Health Realty Income Trust

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/9/2024Buy2,000$37.38$74,760.0011,644View SEC Filing Icon  
3/10/2023Buy1,000$48.12$48,120.009,046View SEC Filing Icon  
5/10/2022Buy2,000$47.88$95,760.007,000View SEC Filing Icon  
7/30/2020Buy1,000$68.33$68,330.004,600View SEC Filing Icon  
9/9/2015Buy1,000$43.60$43,600.001,700View SEC Filing Icon  
See Full Table

Robert F. McCadden Buying and Selling Activity at Universal Health Realty Income Trust

This chart shows Robert F Mccadden's buying and selling at Universal Health Realty Income Trust by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Universal Health Realty Income Trust Company Overview

Universal Health Realty Income Trust logo
Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human-service related facilities including acute care hospitals, behavioral health care hospitals, specialty facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments or commitments in seventy-six properties located in twenty-one states.
Read More

Today's Range

Now: $40.10
Low: $39.97
High: $40.80

50 Day Range

MA: $38.37
Low: $35.32
High: $41.24

2 Week Range

Now: $40.10
Low: $34.56
High: $42.46

Volume

74,439 shs

Average Volume

101,118 shs

Market Capitalization

$556.19 million

P/E Ratio

31.09

Dividend Yield

7.29%

Beta

0.93